anemia
Anemia refers to a condition in which the red blood cell count, hemoglobin content, and hematocrit in a certain volume of circulating blood are all lower than normal standards. Among them, hemoglobin is the most important. If it is lower than 120g/L (12.0g/dl) in adult males and lower than 110g/L (11.0/dl) in adult females, it is generally considered anemia. Anemia is one of the most common clinical manifestations, but it is not an independent disease. It may be an important clinical manifestation of a basic or sometimes more complex disease. Once anemia is found, its cause must be identified. Anemia caused by different reasons includes iron deficiency anemia, hemolytic anemia, megaloblastic anemia, aplastic anemia, thalassemia, sickle cell anemia, congenital dyserythropoietic anemia, sideroblastic anemia, and myelophthisis anemia. Acute and chronic anemia: anemia caused by acute blood loss, chronic anemia (such as rheumatic anemia, anemia caused by infectious diseases, anemia caused by hypothyroidism, anemia caused by liver disease, chronic renal anemia, anemia caused by malignant tumors, etc.).
-
Site of disease:
whole body
-
Infectious :
Not contagious
-
Frequent population:
All people, mainly women, elderly...
-
Related symptoms:
Fatigue
pale skin
loss of appetite
pale or pale conjunctiva
pale lips
-
Concurrent disease:
Related Drugs
Vitamin E soft capsules
Indication: 1. For newborns, premature infants, and low birth weight infants born to mothers who do not eat fortified milk powder or have severe fat malabsorption. 2. Routine use of this product in immature infants and low birth weight infants can prevent hemolytic anemia caused by vitamin E deficiency, and can reduce the formation of retrobulbar fibrous tissue (which can cause blindness) and bronchial-pulmonary system dysplasia caused by oxygen poisoning. However, some people believe that the above effects need further research and confirmation. 3. For the adjuvant treatment of progressive muscular dystrophy.
Manufacturer:
Jiangsu Xinfu Pharmaceutical Co., Ltd.
Recombinant human erythropoietin injection (CHO cells)
Indication: 1. Anemia caused by renal insufficiency, including dialysis and non-dialysis patients. 2. Red blood cell mobilization during perioperative period of surgery. 3. Anemia caused by chemotherapy in the treatment of non-bone malignant tumors. It is not used to treat anemia caused by other factors (such as iron or folate deficiency, hemolysis or gastrointestinal bleeding) in cancer patients.
Manufacturer:
Chengdu DIAO Jiuhong Pharmaceutical Factory
Recombinant human erythropoietin injection (CHO cells)
Indication: 1. Anemia caused by renal insufficiency, including dialysis and non-dialysis patients. 2. Red blood cell mobilization during perioperative period of surgery. 3. Anemia caused by chemotherapy in the treatment of non-bone malignant tumors. It is not used to treat anemia caused by other factors (such as iron or folate deficiency, hemolysis or gastrointestinal bleeding) in cancer patients.
Manufacturer:
NCPC Genetech BIOTECHNOLOGY Co., Ltd.
Recombinant human erythropoietin injection (CHO cells)
Indication: 1. Anemia caused by renal insufficiency, including dialysis and non-dialysis patients. 2. Red blood cell mobilization during perioperative period of surgery. 3. Anemia caused by chemotherapy in the treatment of non-bone malignant tumors. It is not used to treat anemia caused by other factors (such as iron or folate deficiency, hemolysis or gastrointestinal bleeding) in cancer patients.
Manufacturer:
NCPC Genetech BIOTECHNOLOGY Co., Ltd.